» Articles » PMID: 8698507

Virulence Properties of Pseudomonas Aeruginosa Lacking the Extreme-stress Sigma Factor AlgU (sigmaE)

Overview
Journal Infect Immun
Date 1996 Jul 1
PMID 8698507
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

A discerning feature of Pseudomonas aeruginosa strains causing chronic endobronchial infections in cystic fibrosis is their conversion into the mucoid, exopolysaccharide alginate-overproducing phenotype. This morphologically prominent change is caused by mutations which upregulate AlgU (sigma(E)), a novel extreme-stress sigma factor with functional equivalents in gram-negative organisms. In this work, we investigated the role of algU in P. aeruginosa sensitivity to reactive oxygen intermediates, killing by phagocytic cells, and systemic virulence of this bacterium. Inactivation of algU in P. aeruginosa PA01 increased its susceptibility to killing by chemically or enzymatically generated halogenated reactive oxygen intermediates and reduced its survival in bactericidal assays with J774 murine macrophages and human neutrophils. Surprisingly, inactivation of algU caused increased systemic virulence of P. aeruginosa in mouse models of acute infection. The increased lethality of the algU-deficient strain was also observed in the endotoxin-resistant C3H/HeJ mice. Only minor differences between algU+ and algU mutant cells in their sensitivity to human serum were observed, and no differences in their lipopolysaccharide profiles were detected. Intriguingly, while inactivation of algU downregulated five polypeptides it also upregulated the expression of seven polypeptides as determined by two-dimensional gel analyses, suggesting that algU plays both a positive and a negative role in gene expression in P. aeruginosa. While the observation that algU inactivation increases systemic virulence in P. aeruginosa requires further explanation, this phenomenon contrasts with the apparent selection for strains with upregulated AlgU during colonization of the cystic fibrosis lung and suggests opposing roles for this system in chronic and acute infections.

Citing Articles

Pseudomonas aeruginosa biofilm exopolysaccharides: assembly, function, and degradation.

Gheorghita A, Wozniak D, Parsek M, Howell P FEMS Microbiol Rev. 2023; 47(6).

PMID: 37884397 PMC: 10644985. DOI: 10.1093/femsre/fuad060.


The Sigma Factor AlgU Regulates Exopolysaccharide Production and Nitrogen-Fixing Biofilm Formation by Directly Activating the Transcription of in A1501.

Shao Y, Yin C, Lv F, Jiang S, Wu S, Han Y Genes (Basel). 2022; 13(5).

PMID: 35627252 PMC: 9141998. DOI: 10.3390/genes13050867.


Maintaining Integrity Under Stress: Envelope Stress Response Regulation of Pathogenesis in Gram-Negative Bacteria.

Hews C, Cho T, Rowley G, Raivio T Front Cell Infect Microbiol. 2019; 9:313.

PMID: 31552196 PMC: 6737893. DOI: 10.3389/fcimb.2019.00313.


Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.

Malhotra S, Hayes Jr D, Wozniak D Clin Microbiol Rev. 2019; 32(3).

PMID: 31142499 PMC: 6589863. DOI: 10.1128/CMR.00138-18.


Pseudomonas aeruginosa type IV minor pilins and PilY1 regulate virulence by modulating FimS-AlgR activity.

Marko V, Kilmury S, MacNeil L, Burrows L PLoS Pathog. 2018; 14(5):e1007074.

PMID: 29775484 PMC: 5979040. DOI: 10.1371/journal.ppat.1007074.


References
1.
Govan J, Nelson J . Microbiology of lung infection in cystic fibrosis. Br Med Bull. 1992; 48(4):912-30. DOI: 10.1093/oxfordjournals.bmb.a072585. View

2.
Boucher J, Martinez-Salazar J, Schurr M, Mudd M, Yu H, Deretic V . Two distinct loci affecting conversion to mucoidy in Pseudomonas aeruginosa in cystic fibrosis encode homologs of the serine protease HtrA. J Bacteriol. 1996; 178(2):511-23. PMC: 177686. DOI: 10.1128/jb.178.2.511-523.1996. View

3.
Goldberg J, Gorman W, Flynn J, Ohman D . A mutation in algN permits trans activation of alginate production by algT in Pseudomonas species. J Bacteriol. 1993; 175(5):1303-8. PMC: 193215. DOI: 10.1128/jb.175.5.1303-1308.1993. View

4.
Koch C, Hoiby N . Pathogenesis of cystic fibrosis. Lancet. 1993; 341(8852):1065-9. DOI: 10.1016/0140-6736(93)92422-p. View

5.
Martin D, Schurr M, Mudd M, Govan J, Holloway B, Deretic V . Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc Natl Acad Sci U S A. 1993; 90(18):8377-81. PMC: 47359. DOI: 10.1073/pnas.90.18.8377. View